The CIAO (Coronary Interventions Antiplatelet-based Only) StudyA Randomized Study Comparing Standard Anticoagulation Regimen to Absence of Anticoagulation for Elective Percutaneous Coronary Intervention
Eugenio Stabile, MD, PhD, FESC, FAHA*,*,
Wail Nammas, MD*,
Luigi Salemme, MD*,
Giovanni Sorropago, MD*,
Angelo Cioppa, MD*,
Tullio Tesorio, MD*,
Vittorio Ambrosini, MD*,
Esther Campopiano, MD*,
Gregory Popusoi, MD*,
Giuseppe Biondi Zoccai, MD and
Paolo Rubino, MD*
* Laboratory of Invasive Cardiology, Division of Cardiology, Clinica Montevergine, Mercogliano, Italy
Interventional Cardiology, Division of Cardiology, S. Giovanni Battista-Molinette Hospital, University of Turin, Turin, Italy

View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Post-Procedural Myocardial Damage
Creatine kinase-myocardial band (CK-MB) release after percutaneous coronary intervention (PCI) in patients receiving standard anticoagulation therapy (heparin; purple bars) and in patients receiving no anticoagulation therapy (placebo; hatched bars) (p = 0.034).
|
|
|